Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
abbvie
biofourmis
2
×
biotech
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
chronic kidney disease
clinical trials
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
glaxosmithkline
indiana blog main
indiana top stories
life sciences
medical devices
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acceleron pharma
acid sphingomyelinase deficiency
aimmune therapeutics
What
bio
2
×
roundup
abbvie’s
ahead
biofourmis
black
bucks
cancer
celebrate
chance
companies
continue
corner
day
days
debut
diamond
diamond’s
forward
holiday
indication
labor
leading
life
looking
mammoth
march
moves
ohana’s
people
pharma
pop
science
steady
street
summer
therapeutics
wall
waning
week
Language
unset
Current search:
biofourmis
×
photo
×
biotech
×
bio
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More